High-Risk APOL1 Genotype Ups Kidney Failure Risk
Black patients without high-risk APOL1 alleles did not have higher risks for kidney failure.
Black patients without high-risk APOL1 alleles did not have higher risks for kidney failure.
Reducing tumor necrosis factor alpha production using infliximab induction did not improve clinical outcomes in kidney transplant recipients.
Testing for coronary heart disease before kidney transplantation is common practice, but may not be warranted for all patients, according to investigators.
The OPTN policy revision may increase some Black kidney candidates’ total waiting time, which is a major factor in their transplant priority for organ offers.
An antegrade approach is associated with superior stone-free rates, according to a recent meta-analysis.
According to investigators, it is crucial to find the underlying causes of post-transplant anemia and to treat all reversible causes.
Kidney transplantation access increased for some groups, but so did the kidney discard rate.
The update reflects advances in hepatitis C management, such as antiviral therapy, increased use of hepatitis C kidney grafts, and treatment of glomerular diseases associated with the virus.
Longer cold ischemia time alone should not be a rationale for kidney discard, according to investigators.
5.4% decrease seen in probability of any organ placement at age 70 versus 69 years